sublayer
sublayer
sublayer
sublayer
sublayer
sublayer

Rutherford Health plc is at the vanguard of advancing cancer care.

Developing and building a network of oncology centres across the UK known as the Rutherford Cancer Centres, offering a comprehensive range of cancer treatments to patients.

We plan to open a network of centres in the next few years and the first centre in Newport, South Wales, was the first in the UK to offer high energy proton therapy. In addition, each centre also offers radiotherapy, chemotherapy, immunotherapy, diagnostic imaging and supportive care services.

As well as the Rutherford Cancer Centre South Wales, Rutherford Health plc (formerly known as Proton Partners International Limited) has opened two further centres – the Rutherford Cancer Centre North East in Northumberland and the Rutherford Cancer Centre Thames Valley in Reading, with proton therapy now available in both. A fourth site is under construction in Liverpool, the Rutherford Cancer Centre North West.

Rutherford Health plc has partnered with world-leading healthcare technology providers to equip each centre with the very latest and innovative technology, including IBA, Philips and Elekta.

Rutherford Health plc was founded in 2015 by Mike Moran and UK and international cancer experts, including Professor Edward Karol Sikora, former head of the World Health Organisation’s cancer programme. Initial investors include the Wales Life Sciences Investment Fund managed by Professor Sir Chris Evans, the leading life sciences entrepreneur, and the Woodford Patient Capital Trust.



iip livingwage iso9001